Cannabis Inhalers Market 2022

Cannabis Inhalers Market - Global Industry Analysis 2016 - 2020 and Opportunity Assessment 2021 - 2031

PUNE, MAHARASHTRA, INDIA, May 7, 2022 /EINPresswire.com/ -- Cannabis Inhalers Market 2022

This report provides in depth study of “Cannabis Inhalers Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. Cannabis Inhalers Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.persistencemarketresearch.com/samples/32967

According to the latest research by Persistence Market Research, the cannabis inhalers market is set to witness growth of 7.4% CAGR during 2021-2031. Demand for these inhalers is expected to witness an upward increase in the long run as medical use of psychoactive substances has experienced an increased legalization across the globe. With this, various recreational applications are gaining ground. Changing regulatory outlook is what will cause this market to grow in the future.

Cannabinoids are a natural compound found in cannabis plants also known as Cannabis sativa. Apart from the health risks of cannabis intake, controlled and well-monitored doses of these substances can possibly assist in respiratory conditions like Asthma and COPD. This is because of bronchodilation properties of this psychoactive substance.

Inhalers similar to Asthma release a vapour filled with cannabinoids and terpenes. These inhaled substances reach directly the alveoli of the lungs and spread throughout the human body through the blood stream. This direct action enables a very higher bioavailability of the substances. Owing to this and medicinal properties of cannabis, medical applications of these inhalers are being under research and development.

Versatile maneuverability of cannabis inhalers in ailments like stress, anxiety, sleeping disorders, chronic pain, inflammation, asthma, COPD, etc. makes it a front running driver of the market. A 25 October 2019 article from DocMJ listed down bioavailability of cannabis through various routes of administration. Among them, Edibles-4 to 20%, Topical- 5 to 10%, Vapes and Inhalers – 50 to 80%.

The high bioavailability of cannabis through these inhalers is another facet of this topic that will surely serve in boosting the market upward. Cannabis dosage ‘consumption’ can easily transform in ‘over-consumption’ if not monitored properly. This facet will ensure a sturdy acceptance and growth of this market as precise and strict control over the dosage is possible here in comparison to other intake pathways.

Request for Table of Content@https://www.persistencemarketresearch.com/toc/32967

An article was published in European Journal of Pain on 23 May 2020. Researcher here studied the efficiency and safety of a selective-dose cannabis inhaler in victims of chronic pain. It was found that a precise and controlled dosage of cannabis administered through inhalers had an analgesic effect on the subjects. Studies like these may prove to be groundbreaking for inclusion of cannabis into the medical field.

Cannabis is legally banned due to residual effects like addiction if not monitored properly. Federal law says that cannabis is still illegal for sale and use in the US. However, on the state level, 36 US states have legalized cannabis for medicinal and recreational purposes under controlled regulations and environment.

This is a crucial buildout in attaining legal status for cannabis and will boost the American cannabis inhalers market at the forefront.

UK, Germany and Cyprus have deemed cannabis as a prescription medicine; allowing only registered medical practitioners to authorize it to the patient. Patient safety is attained this way and makes it easier to identify measures to be taken against those dealing in cannabis illegally.

Whereas, Sweden, Latvia, Belgium, etc. have put a complete ban on this substance and one cannot import/buy/sell cannabinoids in any legal way. This variation illustrates the partial acceptance of cannabis in Europe. Other European countries have very strict set guidelines and circumstances making Europe second most important market for Cannabis Inhalers.

Key manufacturers in Cannabis Inhalers Market include:

Koi CBD
CBD Luxe
MÜV
Fairwinds Cannabis
Monarch Life Sciences LLC
Weapon Brands
Vectura Group plc
H&T Presspart Manufacturing Ltd.
Syqe Medical Ltd.

Pre-Book Right Now for Exclusive Analyst Support@ https://www.persistencemarketresearch.com/checkout/32967

Cannabis Inhalers Market - Report Highlights

A detailed overview of parent market of Cannabis Inhalers Market
Changing Cannabis Inhalers Market dynamics in the industry
In-depth segmentation of the Cannabis Inhalers Market
Historical, current, and projected Cannabis Inhalers Market size regarding volume and value
Recent industry trends and developments in Cannabis Inhalers Market
Competitive landscape of the Cannabis Inhalers Market
Strategies for key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on Cannabis Inhalers Market performance
Must-have information for Cannabis Inhalers Market players to sustain and enhance their market footprint                                             

Related Reports:

Precision Medicine Market – Global precision medicine market, estimated to be worth around US$ 56 Bn by 2016 end, is expected to expand at an approximate CAGR of 14% from period of 2016–2024.

Opioids Market – The global opioids market is expected to expand at a moderate CAGR of over 3% over the next ten years, and be valued at more than US$ 57 Bn by 2031-end.

About us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Persistence Market Research Pvt. Ltd Atul Singh
PMR
+1 646-568-7751
email us here